Dr. Julieta Marimla Gabiola, MD

Dr. Gabiola practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Gabiola's NPI, 1164562112, was assigned on February 7, 2007. Dr. Gabiola graduated from Rush Medical College in 1982. Dr. Gabiola holds California license G51233.

Dr. Gabiola's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Gabiola's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Gabiola to 1 more hospital, named with a free account. Dr. Gabiola's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gabiola practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gabiola's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gabiola is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gabiola's licenses on file in 2 states: California and Utah.

Dmand AI lists acute sinusitis, acute skin infection, bursitis, conjunctivitis, contact dermatitis, ear infection, enthesopathy in foot or ankle and fluid in a joint among the conditions Dr. Gabiola treats.

CMS data shows 109 Medicare services from Dr. Gabiola across 2 procedure codes in 2024, all of them office visits, for 132 Medicare patients. Medicare paid $8,054 for them. Every service was in an office.

CMS counts 132 Medicare patients who saw Dr. Gabiola in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gabiola's median patient age at 42, with 63% women.

In 2024, Dr. Gabiola wrote 147 Medicare Part D claims for 85 patients. 80% of them were for generic drugs. CMS names the drug for 28 of them, across 1 drug with 11 or more claims each. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gabiola for performance year 2024, reported as part of a group. Dr. Gabiola accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gabiola as offering telehealth.

Dmand AI links 3 papers to Dr. Gabiola in 2019. Dr. Gabiola's most frequent co-authors are Mark Richard Cullen, MD and Latha P. Palaniappan, MD.

CMS Open Payments shows 17 general payments to Dr. Gabiola from 4 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $408.

Dmand AI lists 7 awards for Dr. Gabiola, most recently Humanitarian Award in 2021.

Dr. Gabiola graduated from Rush Medical College in 1982. Dr. Gabiola is a member of ACP.

Dr. Gabiola is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.